Paper Details

  1. Home
  2. Paper Details

Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.

Author: WangLifen, XieBingying, XuLixia, YeZhiming, ZhengQuan

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Hepatitis B virus-associated membranous nephropathy (HBV-MN) is a kidney disease that can occur in patients with chronic hepatitis B infection. Entecavir is an antiviral drug that is used to treat chronic hepatitis B infection. This study evaluated the efficacy of entecavir in the treatment of HBV-MN. The study found that entecavir was effective in improving kidney function in patients with HBV-MN.
Paper Details　
Original Abstract of the Article :
hepatitis B virus-associated membranous nephropathy (HBV-MN) is the most common pathological type of hepatitis B virus-associated glomerulonephritis. This study evaluated the efficacy of entecavir antiviral therapy for HBV-MN patients due to the intolerable side effects of interferon-alpha and high ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.17235/reed.2020.6762/2019

データ提供：米国国立医学図書館（NLM）

Entecavir: A New Hope for HBV-Associated Membranous Nephropathy

Hepatitis B virus (HBV) infection can lead to serious complications, including membranous nephropathy, a kidney disorder. This study investigates the effectiveness of entecavir, an antiviral medication, in treating HBV-associated membranous nephropathy (HBV-MN). The authors examine the efficacy of entecavir in controlling HBV infection and improving kidney function in patients with HBV-MN.

A Battle Against HBV: Seeking Effective Treatment

The research found that entecavir therapy was effective in controlling HBV infection and improving renal function in patients with HBV-MN. It's like a warrior battling a sandstorm, seeking to restore peace and stability to the desert landscape of the kidney. The study's findings suggest that entecavir could be a valuable treatment option for HBV-MN.

A New Path: Exploring Alternatives to Existing Therapies

This study explores the potential of entecavir as an alternative to existing therapies for HBV-MN, such as interferon-alpha and lamivudine, which have limitations in terms of side effects and drug resistance. It's like discovering a new oasis in the desert – offering a fresh perspective and potential solutions for a challenging condition.

Dr.Camel's Conclusion

This study highlights the need for effective treatment options for HBV-MN. The research provides promising evidence for the efficacy of entecavir in controlling HBV infection and improving kidney function. Like a traveler finding a reliable source of water in the desert, entecavir can offer a lifeline for those struggling with HBV-MN.

Date :
  1. Date Completed 2021-06-23
  2. Date Revised 2021-06-23
Further Info :

Pubmed ID

33054304

DOI: Digital Object Identifier

10.17235/reed.2020.6762/2019

Related Literature

Article Analysis
・Side Effects of entecavir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.